{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:50:16Z","timestamp":1765446616155,"version":"3.46.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["fertstertreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["F&S Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.xfre.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T15:18:09Z","timestamp":1756135089000},"page":"470-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progestin-suppressed in vitro fertilization cycles yield similar outcomes to traditional protocols in patients with diminished ovarian reserve"],"prefix":"10.1016","volume":"6","author":[{"given":"Sara C.","family":"Pierpoint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison M.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary C.","family":"Peavey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott H.","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0466-1554","authenticated-orcid":false,"given":"Linnea R.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xfre.2025.08.007_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fertnstert.2021.02.036","article-title":"Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial","volume":"116","author":"Giles","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.fertnstert.2024.01.026","article-title":"Oral medroxyprogesterone acetate for the use of ovulation suppression in in vitro fertilization: a cohort trial","volume":"121","author":"Welp","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle-stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"15","author":"Borm","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.08.007_bib5","first-page":"28","article-title":"GnRH antagonists in ovarian stimulation\u2014future standard in IVF?","volume":"5","author":"Ludwig","year":"2002","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2025.08.007_bib6","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2025.08.007_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1210\/endo-109-4-1293","article-title":"On the site of action of progesterone in the blockade of the estradiol-induced gonadotropin discharge in the rhesus monkey","volume":"109","author":"Wildt","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfre.2025.08.007_bib8","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1210\/endo-110-4-1454","article-title":"Mode of action of progesterone in the blockade of gonadotropin surges in the rhesus monkey","volume":"110","author":"Pohl","year":"1982","journal-title":"Endocrinology"},{"key":"10.1016\/j.xfre.2025.08.007_bib9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0015-0282(16)58335-6","article-title":"Premature progesterone elevation does not alter oocyte quality in in vitro fertilization","volume":"65","author":"Fanchin","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.fertnstert.2012.03.014","article-title":"Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles","volume":"97","author":"Xu","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.fertnstert.2017.05.007","article-title":"Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates","volume":"108","author":"Wang","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib12","first-page":"91","article-title":"Comparison of concomitant outcome achieved with fresh and cryopreserved oocytes in IVF\u2013ICSI cycles: a prospective, randomized, multicenter study","volume":"21","author":"Cobo","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2025.08.007_bib13","article-title":"Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.xfre.2025.08.007_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Beguer\u00eda","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.08.007_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2019.07.628","article-title":"Dydrogesterone for prevent LH surge yields similar outcomes to ganirelix in a shared oocyte donor cycle with subsequent frozen-thawed embryo transfer: comparison of donors and recipients","volume":"112","author":"Cambiaghi","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.fertnstert.2020.08.636","article-title":"The use of dydrogesterone to prevent LH peak in random-start ovarian stimulation for fertility preservation","volume":"114","author":"Braham","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.xfre.2025.08.007_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2020.00129","article-title":"Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization: a single-center non-inferiority randomized controlled trial","volume":"11","author":"Guo","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xfre.2025.08.007_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-018-0335-0","article-title":"An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders","volume":"16","author":"Huang","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.xfre.2025.08.007_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.xfre.2025.08.007_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2015.05.017","article-title":"Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System","volume":"104","author":"Devine","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.xfre.2025.08.007_bib22","article-title":"The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xfre.2025.08.007_bib23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.08.007_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.xfre.2025.08.007_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial","volume":"12","author":"Qianwen","year":"2020","journal-title":"Clinical Epidemiol"},{"key":"10.1016\/j.xfre.2025.08.007_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.21037\/atm-20-1592","article-title":"Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.xfre.2025.08.007_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.xfre.2025.08.007_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/dead038","article-title":"The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF","volume":"38","author":"Massin","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.xfre.2025.08.007_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deae104","article-title":"Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh)","author":"Racca","year":"2024","journal-title":"Hum Reprod"}],"container-title":["F&S Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334125001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666334125001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:47:12Z","timestamp":1765446432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666334125001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2666334125001217"],"URL":"https:\/\/doi.org\/10.1016\/j.xfre.2025.08.007","relation":{},"ISSN":["2666-3341"],"issn-type":[{"type":"print","value":"2666-3341"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin-suppressed in vitro fertilization cycles yield similar outcomes to traditional protocols in patients with diminished ovarian reserve","name":"articletitle","label":"Article Title"},{"value":"F&S Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xfre.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}